The latest biotechnology news | Bio News
BOTAR Richmond

BIO visit shines a spotlight on Virginia’s biotech ecosystem

With more than $1 billion in R&D expenditures in 2022 and 415 new ...
Read More
biotch workforce

Life sciences job report shows growth slowing, but firms still invest in talent

As the United States has long been a life sciences leader, the health ...
Read More
BIO 2025 IP

Protect IP protections, BIO 2025 panel urges

Given the essential role that intellectual property plays in the development of lifesaving ...
Read More
IMG_7907

BIO 2025: The urgent need to address AMR and cancer

As antimicrobial resistance (AMR) continues to threaten global public health, its impact on ...
Read More
drug patent

BIO expert explains patents at DOJ and FTC listening session

Patents enable the innovation that produces new lifesaving treatments while ensuring a competitive ...
Read More
Fritz Bittenbender

A conversation with Fritz Bittenbender, new BIO Board Chair

The exciting new developments we’re seeing in biotechnology must be supported by equally ...
Read More
Save with Avantor and BIO Business Solutions

EDITORS' CHOICE

Fritz Bittenbender

A conversation with Fritz Bittenbender, new BIO Board Chair

The exciting new developments we’re seeing in biotechnology must be supported by equally innovative policy, according to Fritz Bittenbender, the new Chair of the Board ...
Read More

LATEST NEWS

Latest News

BIO visit shines a spotlight on Virginia’s biotech ecosystem

With more than $1 billion in R&D expenditures in 2022 and 415 new patents in 2023, the bioscience sector in Virginia is making an important ...
Bioeconomy

Life sciences job report shows growth slowing, but firms still invest in talent

As the United States has long been a life sciences leader, the health of the life sciences sector is a pretty good indicator of overall ...
BIO Events

Protect IP protections, BIO 2025 panel urges

Given the essential role that intellectual property plays in the development of lifesaving scientific advances, we need to defend and strengthen policy that protects IP, ...
BIO Events

BIO 2025: The urgent need to address AMR and cancer

As antimicrobial resistance (AMR) continues to threaten global public health, its impact on cancer patients is a growing, often overlooked crisis. Patients with cancer are ...
Federal Policy

BIO expert explains patents at DOJ and FTC listening session

Patents enable the innovation that produces new lifesaving treatments while ensuring a competitive market, the top IP expert for the Biotechnology Innovation Organization (BIO) told ...

Welcome, John F. Crowley!

Get to know John F. Crowley, the new President and CEO of the Biotechnology Innovation Organization (BIO), in our exclusive interview.

Federal Policy

State Policy

International

Bio's View